Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
Proc Natl Acad Sci U S A
; 113(6): 1624-9, 2016 Feb 09.
Article
in En
| MEDLINE
| ID: mdl-26811457
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Sulfonamides
/
Hodgkin Disease
/
Antineoplastic Combined Chemotherapy Protocols
/
Immunoconjugates
/
Aniline Compounds
Type of study:
Prognostic_studies
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2016
Document type:
Article
Country of publication:
United States